Institutional accumulation regime. Strong business quality combined with supportive market trend. Valuations remain balanced and supported by current metrics.
SENTINEL REVIEW
AVT Natural Products Limited (AVTNPL)•Updated yesterday
🚨 Structural Deterioration Signature: In FY2026, AVT Natural Products Limited is experiencing severe earnings quality strain, marked by a 34.4% YoY deterioration in reported net profit to ₹64.8 Cr and persistent margin compression: EBIT margins fell to 15.8% from 19.6% YoY, signaling operational inefficiency and an elevated risk ranking within the FMCG sector. This operating deterioration is compounded by operational friction: inventory turnover is slowing, trade receivables are rising, and cash conversion is under stress, contributing to a 136.9% YoY growth in operating cash flow to ₹12.0 Cr. Against this liquidity strain, total debt expanded 4.3% to ₹113.6 Cr, pushing debt-to-equity to 0.2x and entering Flagium's heightened surveillance range. The company's receivables-revenue divergence and inventory buildup further exacerbate working capital pressure, with receivable days rising to 96.4 and inventory levels at ₹320.6 Cr. These signals suggest structural strain in the cash flow cycle and channel demand, requiring vigilant monitoring.
- ✗Risk score deteriorated (QoQ change: +12 pts)
- ✓Profitability margins pressure eased
- ✓Working Capital Expansion resolved this quarter (6.4 pts)
- ✗New risk trigger: Receivables-Revenue Divergence (+13 pts)
- ✗Growth expectations are demanding
- ✓Market structure is strong
- ✗Institutional flow regime is Neutral (0.07σ)
- ✓Share price is up +0.5% this quarter (from ₹91.29 on 30 Sept to ₹91.76)
- 🔴Investigate Universal Inventory Divergence and balance sheet impact
- 🟢Working Capital Expansion resolved in latest filing; verify sustainability in next filing
- 🟢Maintain routine quarterly surveillance; no governance escalation required
- 9.7 ptsEarnings Quality
- 8.1 ptsBalance Sheet Stress
Divergence Radar
Structural Matrix
Risk vs Price TimelineVisualizing the historical relationship between the structural risk score and stock price movement over time.
| Duration | Perf. | Sector Avg | Divergence |
|---|---|---|---|
| 1 Week | +0.12% | -1.46% | +1.58% |
| 1 Month | +5.95% | -6.69% | +12.64% |
| 6 Months | +32.41% | +6.82% | +25.59% |
| 1 Year | +34.74% | +8.93% | +25.82% |
| 2 Year | +15.76% | +47.64% | -31.89% |
| 3 Year | +11.32% | +125.5% | -114.18% |
Business Analysis Methodology
Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.
Financial profile remains stable for now. Weakness is detected in profitability and earnings quality. No immediate concerns are visible. Risk is increasing at a faster pace.
Risk Score Composition
Investment Risk Thesis
Current risk score has risen from 4 → 18 over 14 quarters.
- Operating profit margins
- Inventory turnover
Risk Drivers (Active Warnings)
Primary Driver & Insights
Working capital cycles are stretching, led by receivables-revenue divergence. This delays cash generation from core operations and locks up liquidity.
Active Risk Objects (10)Free Preview (2 of 10)
AVTNPL: Trade Receivables growth outpaced Revenue by +92.3 pp (DSRI: 2.22x).
Early signs of slowing collections. Monitor for pressure on the cash flow cycle.
AVTNPL: Inventory growth outpaced Revenue growth by +16.6 pp (Inventory holding ratio increased +22.0%).
Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously.
Unlock All 10 Forensic Signals (8 Additional Warnings Gated)
Free accounts preview the top 2 highest-impact warning signals. Upgrade to Flagium Pro to inspect all 10 active forensic detectors, multi-quarter duration streaks, and financial stress metrics for AVT Natural Products Limited.
Statutory Note: Forensic signals are algorithmic quantitative observations derived from publicly filed XBRL disclosures and do not constitute allegations of legal misconduct or investment recommendations.
Unlock Interactive Signal Evidence Dossier
Access complete multi-quarter financial evidence, 5-KPI snapshot strips, diagnostic hypotheses, and 1-page forensic PDF dossiers for AVT Natural Products Limited.
Structural Risk Attribution
Deterministic quarter-on-quarter causal decomposition grounded in statutory exchange filings.
Structural History · Last 12 QuartersHistorical Trajectory (12Q)
Risk deteriorated notably (+12.0 pts), driven by new Receivables-Revenue Divergence (+13.0 pts) and new Universal Inventory Divergence (+8.1 pts), partially offset by Working Capital Expansion relief (-6.4 pts).
12-Quarter Structural Regimes & Landmark Inflections12Q Structural Regimes & Inflections
Risk deteriorated materially (+21.0 pts), driven by new Inventory Stress (+18.0 pts) and new Margin Compression (+16.2 pts).
Business Resilience & Benchmark Context
Overall: STRONGPEER COMPARISON MATRIX
Ranked surveillance & credit risk comparison against sector peers
Stable
Stable
Watch
Watch
Watch
Watch
* Peer comparison is based on risk signals, not valuation or returns.
Unlock 5-Year Forensic Divergence Cockpit
Access multi-year visual divergence charts (EBITDA vs CFO Cash Gap, Receivables Decoupling Spread, and Debt vs FCF Burn) for AVT Natural Products Limited.
FINANCIAL STATEMENTS
Working Capital & Forensic Monitor
Operating Cycle Disclosures·10 Fiscal Years
Working Capital Schedule (INR Cr)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Trade Receivables(₹ Cr) | 240 | 156 | 110 | 121 | — | — | — | — | — | — |
Inventories(₹ Cr) | 321 | 294 | 221 | 212 | — | — | — | — | — | — |
Trade Payables(₹ Cr) | 132 | 99 | 59 | 28 | — | — | — | — | — | — |
Net Working Capital(₹ Cr) | 429 | 351 | 272 | 306 | — | — | — | — | — | — |
Working Capital / Sales(%) | 59.0% | 61.3% | 51.4% | 52.3% | — | — | — | — | — | — |
Cash Conversion & Operating Cycle (Days)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Conversion Cycle (CCC)(days) | 216d | 224d | 188d | 191d | — | — | — | — | — | — |
Debtor Days (DSO)(days) | 121d | 100d | 76d | 76d | — | — | — | — | — | — |
Inventory Days (DIO)(days) | 161d | 187d | 152d | 132d | — | — | — | — | — | — |
Creditor Days (DPO)(days) | 66d | 63d | 40d | 17d | — | — | — | — | — | — |
Forensic Accounting Monitor & Divergences
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Receivable Growth vs Sales (Δ)(%) | +26.7% | +34.2% | -0.1% | — | — | — | — | — | — | — |
Inventory Growth vs Sales (Δ)(%) | -17.9% | +24.8% | +13.7% | — | — | — | — | — | — | — |
Asset Growth vs Sales (Δ)(%) | -13.9% | +16.9% | +24.0% | — | — | — | — | +14.5% | -3.1% | — |
Earnings-to-Cash Divergence (PAT - CFO)(₹ Cr) | 53 | 81 | -45 | 26 | -2 | — | — | 10 | 8 | -12 |
Accrual Ratio (Accruals / Avg Assets)(%) | 6.6% | 12.0% | -8.1% | 5.0% | — | — | — | 3.3% | 3.0% | -4.8% |
Operating Cash Realisation (CFO / EBITDA)(%) | 14.5% | -51.5% | 138.6% | 49.0% | 76.9% | — | — | 42.4% | 38.1% | 87.2% |
Capitalisation Intensity (CWIP / Assets)(%) | — | — | — | — | — | — | — | — | — | — |
Industry Intelligence
FMCG Sector KPIs| Operating Driver | Quarter | Current Value | Change (QoQ) | Change (YoY) | Industry Median |
|---|---|---|---|---|---|
| Q1 FY2027 | 70.5% | +720 bps ↑ Operating efficiency gains | -1610 bps ↓ Profitability contraction | 48.5% |
Understanding FMCG KPIs
Concall & Management Takeaways
No investor earnings call transcripts transcribed for this scrip.
Earnings call intelligence is automatically populated when companies conduct quarterly earnings calls with institutional investors and publish transcripts.
Business quality remains strong.
Current forensic pressure is elevated and stable.
Key risks remain concentrated in growth sustainability and operating leverage.
The structural architecture is currently robust. Capital resilience buffers in earnings quality remain well-maintained against forensic benchmarks. Systematic scans of operational margins and profitability metrics confirm the absence of material structural stress. Strategic vigilance is advised as structural decay is accelerating.
Market Expectation Engine
Investor Translation • What the market price is expecting
Expectation EngineAt the current price of ₹92, the market expects this company to grow its revenue by 10.0% every year for the next 5 years. If you think the company will grow faster than 10.0%, current market prices reflect a discount relative to that growth assumption.
Sentinel Takeaway:The market expects future growth in line with the company's historical delivery. Current market expectations appear balanced relative to the business's track record, representing standard expectation risk.
Using the Implied Revenue Model, the market is pricing AVTNPL for 10.0% implied revenue growth versus 7.5% observed 3Y revenue CAGR. Current expectations appear elevated, and trailing fundamentals provide moderate support.
Business Delivery Capacity
Performance quality vs historical benchmarksHistorical business performance currently provides moderate support for the market's implied growth assumptions. Improvement in revenue growth and operating efficiency would strengthen expectation support.
WHY IS EXPECTATION RISK ELEVATED?
Valuation Context
WHAT MUST HAPPEN FOR CURRENT PRICE TO BE CORRECT?
| Assumption Metric | Required (To justify current price) | Historical Delivery (Average) | Fulfillment Assessment |
|---|---|---|---|
| Revenue Growth (CAGR) | 10.0% | 7.5% | Achievable |
| Operating Margin (EBIT) | 12.5% | 11.9% | Demanding |
| Free Cash Flow Conversion | -9.3% | 11.3% | Achievable |
*Required metrics indicate the operating efficiency and revenue expansion parameters that must be sustained long-term to justify the current stock price.
The current valuation assumes business performance broadly in line with the company's historical record. Historical operating performance currently provides limited evidence that these expectations are sustainable. Continued stronger profitability and stronger cash generation would be required to justify current pricing.
Market Structure Methodology
Flagium separates Business Risk from Market Structure. Business analysis explains what is happening inside the company. Market Structure measures how investors are behaving through price trends, momentum, participation, and institutional activity. Divergences between the two often reveal important transitions before they become obvious.
The stock remains in a confirmed Stage 2 advancing phase. Institutional participation remains neutral, while trend quality stays constructive and momentum is accelerating. Current price action continues to support the prevailing advance.
What Is Driving Market Structure?
Market structure shows partial alignment with the underlying fundamental risk profile.
Market Cycle Stage Analysis
Stan Weinstein 4-Stage CycleMomentum & Institutional Flow
Methodology & Regulatory Disclaimer
Flagium AI is an automated financial data analytics and research platform providing quantitative risk, forensic, and valuation analytics for informational and educational purposes only. Flagium AI is not registered with SEBI as a Research Analyst or Investment Adviser under SEBI regulations. These analytics do not constitute financial planning, investment advice, or recommendations to buy, sell, or hold any security.
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered Investment Adviser before acting on any data presented.
📬 Flagium Risk Brief — Track forensic risks on AVTNPL & 3 market anomalies weekly
See a sample issue →